MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Revenue
$570,332K
Net Income
$99,693K
Net Profit Margin
17.48%
EPS
$2.28
Unit: Thousand (K) dollars
Revenue Breakdown
Vascular Access
Interventional
Surgical
Revenue Breakdown
Americas Segment
EMEASegment
Asia Segment
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-28
Net revenues
570,332
548,262
-401,866
913,021
Cost of goods sold
238,625
240,836
-250,454
461,379
Gross profit
331,707
307,426
-151,412
451,642
Selling, general and administrative expenses
213,515
226,012
614
281,764
Research and development expenses
45,122
44,386
12,628
57,228
Pension settlement charge
-
-
0*
0
Goodwill impairment
-
-
-
403,925
Restructuring charges, separation costs and impairment charges
246
16,845
-7,119
117,623
Gain on sale of assets and business
-
-
403,925*
-
Income from continuing operations before interest, taxes and loss on extinguishment of debt
72,824
20,183
246,390
-408,898
Interest expense
27,953
25,718
28,130
31,841
Interest income
1,416
1,708
680
2,163
Loss on extinguishment of debt
-1,150
-
-
-
Income from continuing operations before taxes
45,137
-3,827
218,940
-438,576
Taxes on income from continuing operations
3,375
1,011
-30,779
-29,699
Income from continuing operations
41,762
-4,838
249,719
-408,877
Operating income from discontinued operations
60,254
-2,643
-1,097,017
-20
Taxes on operating income from discontinued operations
2,323
673
-132,968
-5
Income from discontinued operations
57,931
-3,316
-964,049
-15
Net income
99,693
-8,154
-714,330
-408,892
Basic EPS
2.29
-0.18
-16.161
-9.24
Diluted EPS
2.28
-0.18
-16.088
-9.24
Basic Average Shares
43,562,000
44,257,000
44,200,000
44,237,000
Diluted Average Shares
43,660,000
44,257,000
44,401,000
44,237,000
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
1
2
Vascular Access
$246,337K
(32.77%↑ Y/Y)
Interventional
$211,874K
(24.62%↑ Y/Y)
Surgical
$112,121K
(-1.68%↓ Y/Y)
Net revenues
$570,332K
(-26.96%↓ Y/Y)
Gross profit
$331,707K
(-23.05%↓ Y/Y)
Cost of goods sold
$238,625K
(-31.78%↓ Y/Y)
Income from continuing
operations before...
$72,824K
(-53.11%↓ Y/Y)
Interest income
$1,416K
(-13.82%↓ Y/Y)
Selling, general and
administrative expenses
$213,515K
(-0.73%↓ Y/Y)
Research and development
expenses
$45,122K
(17.14%↑ Y/Y)
Restructuring charges,
separation costs and...
$246K
(-98.89%↓ Y/Y)
Operating income from
discontinued operations
$60,254K
(1506450.00%↑ Y/Y)
Income from continuing
operations before taxes
$45,137K
(-66.63%↓ Y/Y)
Interest expense
$27,953K
(28.77%↑ Y/Y)
Loss on
extinguishment of debt
-$1,150K
Income from
discontinued operations
$57,931K
(1448375.00%↑ Y/Y)
Income from continuing
operations
$41,762K
(-65.93%↓ Y/Y)
Taxes on operating
income from...
$2,323K
Taxes on income from
continuing operations
$3,375K
(-73.35%↓ Y/Y)
Net income
$99,693K
(-18.67%↓ Y/Y)
Buy us a coffee
TFX_BIG-svg
TELEFLEX INC (TFX)
TFX_BIG-svg
TELEFLEX INC (TFX)